Answers are grounded in this paper and cite their sources.
iLND improves survival by assessing selective lymph node regions in vulvar carcinoma, suggesting a new treatment method.
iLND provides a biologically grounded and anatomically precise strategy for regional management of vulvar carcinoma. By targeting high-risk nodal regions only, it enables therapeutic de-escalation while improving survival without reliance on radiotherapy or nuclear medicine. This benefit is relevant across healthcare systems and furthermore makes iLND suitable for low-resource settings.
No takes yet. Share an insight, caveat, or question.
Höckel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: